Gelişmiş Arama

Basit öğe kaydını göster

dc.contributor.authorCanbakan B.
dc.contributor.authorTahan V.
dc.contributor.authorBalci H.
dc.contributor.authorHatemi I.
dc.contributor.authorErer B.
dc.contributor.authorOzbay G.
dc.contributor.authorSenturk H.
dc.date.accessioned2019-08-13T12:10:23Z
dc.date.accessioned2019-08-13T15:53:36Z
dc.date.available2019-08-13T12:10:23Z
dc.date.available2019-08-13T15:53:36Z
dc.date.issued2008
dc.identifier.urihttp://hdl.handle.net/11446/1976
dc.descriptionPubMed ID: 18753993en_US
dc.description.abstractBackground: Non-alcoholic fatty liver disease (NAFLD) is a prevalent condition associated with obesity and insulin resistance (IR). Leptin plays a key role in the control of energy balance, and insulin sensitivity. In this study, we aimed to examine whether serum leptin levels correlate with insulin resistance, oxidative stress parameters and the severity of histological changes in NAFLD. Methods: Fifty-two patients (M/F: 28/24) with no alcohol intake and biopsy-proven diagnosis of NAFLD were studied. Serum leptin levels were measured by radioimmunoassay. HOMA (homeostasis model assessment) IR index was calculated. Comparisons between the patients with NAFLD and non-alcoholic steatohepatitis (NASH) were performed using the Student's t test. Multivariate regression analysis and the area under the receiver operating characteristic (ROC) curve were used to identify the independent predictors for NASH. Results: We found no association between serum leptin, fasting insulin levels, and oxidative stress parameters. ROC curve and multiple regression analysis revealed no association between the severity of histological changes and serum leptin levels. During six months followed-up period only NASH group with elevated leptin levels had significant reductions of ALT and AST values (p = 0.03, and 0.005, respectively). Conclusion: Our findings show a preventive effect of leptin against progressive liver injury in NAFLD.en_US
dc.language.isoengen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectInsulin resistanceen_US
dc.subjectLeptinen_US
dc.subjectNon-alcoholic fatty liver diseaseen_US
dc.subjectReactive oxygen speciesen_US
dc.titleLeptin in nonalcoholic fatty liver diseaseen_US
dc.typearticleen_US
dc.relation.journalAnnals of Hepatologyen_US
dc.departmentDBÜen_US
dc.identifier.issue3en_US
dc.identifier.volume7en_US
dc.identifier.startpage249en_US
dc.identifier.endpage254en_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.department-tempDBÜen_US


Bu öğenin dosyaları:

DosyalarBoyutBiçimGöster

Bu öğe ile ilişkili dosya yok.

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster